Cargando…

A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development

Malaria continues to be a pressing global health issue, causing nearly half a million deaths per year. An effective malaria vaccine could radically improve our ability to control and eliminate this pathogen. The most advanced malaria vaccine, RTS,S, confers only 30% protective efficacy under field c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atcheson, Erwan, Hill, Adrian V. S., Reyes-Sandoval, Arturo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016880/ https://www.ncbi.nlm.nih.gov/pubmed/33795695 http://dx.doi.org/10.1038/s41541-021-00302-x

Ejemplares similares

Protective efficacy of peptides from Plasmodium vivax circumsporozoite protein
por: Atcheson, Erwan, et al.
Publicado: (2020)

Restricted valency (NPNA)(n) repeats and junctional epitope-based circumsporozoite protein vaccines against Plasmodium falciparum
por: Langowski, Mark D., et al.
Publicado: (2022)

Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite protein
por: Oyen, David, et al.
Publicado: (2020)

Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2014)

Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications
por: Gandhi, Kavita, et al.
Publicado: (2016)

Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development
por: Miyazaki, Yukiko, et al.
Publicado: (2020)

An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein
por: Jelínková, Lucie, et al.
Publicado: (2021)

Diversity of T Cell Epitopes in Plasmodium falciparum Circumsporozoite Protein Likely Due to Protein-Protein Interactions
por: Aragam, Nagesh R., et al.
Publicado: (2013)

Monoclonal Antibodies against Plasmodium falciparum Circumsporozoite Protein
por: Zhang, Min, et al.
Publicado: (2017)

A multivalent Plasmodium falciparum circumsporozoite protein‐based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats
por: Pendyala, Geetanjali, et al.
Publicado: (2023)

Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
por: Marin-Mogollon, Catherin, et al.
Publicado: (2018)

Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax
Publicado: (1982)

Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population
por: Kusi, Kwadwo A., et al.
Publicado: (2020)

Effect of antibodies on the expression of Plasmodium falciparum circumsporozoite protein gene
por: Jesuíno, B S, et al.
Publicado: (2006)

Malaria vaccine peptide Plasmodium falciparum circumsporozoite protein gene cloning in vaccinia virus
Publicado: (1989)

Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein
por: Wang, Lawrence T., et al.
Publicado: (2021)

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice
por: Atcheson, Erwan, et al.
Publicado: (2019)

Discovery of four new B-cell protective epitopes for malaria using Q beta virus-like particle as platform
por: Atcheson, Erwan, et al.
Publicado: (2020)

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
por: Sedegah, Martha, et al.
Publicado: (2013)

Optimization of a Plasmodium falciparum circumsporozoite protein repeat vaccine using the tobacco mosaic virus platform
por: Langowski, Mark D., et al.
Publicado: (2020)

A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein
por: Zhang, Min, et al.
Publicado: (2016)

Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS,S Malaria Vaccine
por: Zeeshan, Mohammad, et al.
Publicado: (2012)

Protective Efficacy of Baculovirus Dual Expression System Vaccine Expressing Plasmodium falciparum Circumsporozoite Protein
por: Iyori, Mitsuhiro, et al.
Publicado: (2013)

Plant-produced transmission blocking Plasmodium falciparum Pfs25 subunit and VLP based vaccine candidates
por: Musivchuk, Konstantin, et al.
Publicado: (2012)

Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite protein
por: Oyen, David, et al.
Publicado: (2017)

Diverse Antibody Responses to Conserved Structural Motifs in Plasmodium falciparum Circumsporozoite Protein
por: Pholcharee, Tossapol, et al.
Publicado: (2020)

How to induce protective humoral immunity against Plasmodium falciparum circumsporozoite protein
por: Wahl, Ilka, et al.
Publicado: (2022)

Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
por: Mohamed, Nouh Saad, et al.
Publicado: (2021)

Tailoring a Plasmodium vivax Vaccine To Enhance Efficacy through a Combination of a CSP Virus-Like Particle and TRAP Viral Vectors
por: Atcheson, Erwan, et al.
Publicado: (2018)

Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein
por: Gregson, Aric L., et al.
Publicado: (2008)

T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution?
por: Jalloh, Amadu, et al.
Publicado: (2009)

Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens
por: Dennison, S. Moses, et al.
Publicado: (2018)

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains
por: Noe, Amy R., et al.
Publicado: (2021)

Protective Antibody and CD8(+) T-Cell Responses to the Plasmodium falciparum Circumsporozoite Protein Induced by a Nanoparticle Vaccine
por: Kaba, Stephen A., et al.
Publicado: (2012)

Tailoring a Combination Preerythrocytic Malaria Vaccine
por: Bauza, Karolis, et al.
Publicado: (2016)

Rationale for Further Development of a Vaccine Based on the Circumsporozoite Protein of Plasmodium vivax
por: Yadava, Anjali, et al.
Publicado: (2017)

Head-to-Head Comparison of Soluble vs. Qβ VLP Circumsporozoite Protein Vaccines Reveals Selective Enhancement of NANP Repeat Responses
por: Khan, Farhat, et al.
Publicado: (2015)

Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine
por: McCoy, Margaret E, et al.
Publicado: (2013)

Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine
por: McCoy, Margaret E, et al.
Publicado: (2013)

Comparative population structure of Plasmodium falciparum circumsporozoite protein NANP repeat lengths in Lilongwe, Malawi
por: Bowman, Natalie M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_029bn86umhuoboh37jdrdfacsh